[1]
Kadıyoran, C. et al. 2025. Syndecan-1 as a Biomarker for Cardiovascular Risk in Patients with Behçet’s Disease. Archives of Rheumatology. 40, 4 (Dec. 2025), 435–442. DOI:https://doi.org/10.5152/ArchRheumatol.2025.11178.